Key Takeaways
- • International Flavors & Fragrances (IFF) has agreed to sell its Food Ingredients business to CVC Capital Partners for $4.3 billion enterprise value, representing a 10x EBITDA multiple.
- • IFF will retain a 10% minority equity interest (approximately $200 million) in the divested business and maintain board representation, allowing continued participation in future value creation.
- • IFF expects to receive approximately $3.8 billion in net cash proceeds on closing, which will be directed toward debt reduction and balance sheet strengthening.
- • The transaction represents the 13th non-core divestiture by IFF, generating nearly $10 billion in cumulative gross proceeds as part of its broader portfolio optimization strategy.
- • The deal is expected to close by the end of Q2 2027, subject to regulatory approvals, and will allow IFF to sharpen strategic focus on higher-growth, higher-margin segments: Taste, Scent, and Health & Biosciences.
Summary
International Flavors & Fragrances announced a definitive agreement to divest its Food Ingredients business to CVC Capital Partners in a transaction valued at approximately $4.3 billion on an enterprise value basis. The sale represents a strategic portfolio realignment by IFF, allowing the company to concentrate resources on three core innovation-driven segments: Taste, Scent, and Health & Biosciences. IFF's CEO Erik Fyrwald characterized the transaction as "an important strategic milestone in our ongoing portfolio optimization initiative," emphasizing that simplifying the portfolio will accelerate innovation and R&D investment while enabling better integration of biotechnology and naturals capabilities across the global platform.
The deal structure includes a meaningful minority stake retention by IFF: the company will hold an approximately 10% equity interest in the divested Food Ingredients business, valued at around $200 million, along with a board seat. This approach permits continued collaboration and allows IFF shareholders to participate in future value creation under CVC's ownership. Upon closing, IFF expects to receive approximately $3.8 billion in net cash proceeds, which management has committed to deploying toward debt reduction and improving financial flexibility. The 10x EBITDA valuation multiple reflects market confidence in the Food Ingredients unit's cash flow characteristics and operational performance.
The divestiture forms part of IFF's broader portfolio transformation campaign. Including this transaction, IFF has now completed 13 non-core business dispositions, collectively generating nearly $10 billion in gross proceeds. This disciplined capital allocation approach has funded the company's strategic repositioning and debt management objectives. The transaction is expected to close by the end of Q2 2027, contingent upon regulatory approvals and customary closing conditions. The sale positions IFF as a more focused, higher-growth enterprise with improved cash flow dynamics and a strengthened balance sheet, positioning the company to achieve its medium and long-term profitability and growth targets.
The deal structure includes a meaningful minority stake retention by IFF: the company will hold an approximately 10% equity interest in the divested Food Ingredients business, valued at around $200 million, along with a board seat. This approach permits continued collaboration and allows IFF shareholders to participate in future value creation under CVC's ownership. Upon closing, IFF expects to receive approximately $3.8 billion in net cash proceeds, which management has committed to deploying toward debt reduction and improving financial flexibility. The 10x EBITDA valuation multiple reflects market confidence in the Food Ingredients unit's cash flow characteristics and operational performance.
The divestiture forms part of IFF's broader portfolio transformation campaign. Including this transaction, IFF has now completed 13 non-core business dispositions, collectively generating nearly $10 billion in gross proceeds. This disciplined capital allocation approach has funded the company's strategic repositioning and debt management objectives. The transaction is expected to close by the end of Q2 2027, contingent upon regulatory approvals and customary closing conditions. The sale positions IFF as a more focused, higher-growth enterprise with improved cash flow dynamics and a strengthened balance sheet, positioning the company to achieve its medium and long-term profitability and growth targets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.